context
stringlengths
21
33.9k
category
stringclasses
2 values
entity
stringlengths
1
12
entity_type
stringclasses
5 values
query
stringlengths
97
3.31k
answer
stringlengths
12
169
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
150.0
monetaryItemType
text: <entity> 150.0 </entity> <entity type> monetaryItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing fo...
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
10.0
monetaryItemType
text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for...
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
125
percentItemType
text: <entity> 125 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for i...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
1.25
percentItemType
text: <entity> 1.25 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for ...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
50
percentItemType
text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for it...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
0.50
percentItemType
text: <entity> 0.50 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for ...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
100
percentItemType
text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for i...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for its guarantee of the payment and performance of the obligations under the Loan Agreem...
text
1.00
percentItemType
text: <entity> 1.00 </entity> <entity type> percentItemType </entity type> <context> On the Closing Date, the Borrower and lender entered into a Loan Agreement (as it may be amended from time to time, the “Loan Agreement”) providing for the Credit Facility, and the Guarantor executed a Guaranty Agreement providing for ...
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
On August 11, 2016 in connection with the Company's IPO, the Board approved the 2016 Incentive Award Plan (the “2016 Plan”). The 2016 Plan provides for long-term equity incentive compensation for key employees, officers and non-employee directors. A variety of discretionary awards (collectively, the “Awards”) for emplo...
text
6000000
sharesItemType
text: <entity> 6000000 </entity> <entity type> sharesItemType </entity type> <context> On August 11, 2016 in connection with the Company's IPO, the Board approved the 2016 Incentive Award Plan (the “2016 Plan”). The 2016 Plan provides for long-term equity incentive compensation for key employees, officers and non-emplo...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
206893
sharesItemType
text: <entity> 206893 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
131156
sharesItemType
text: <entity> 131156 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
24650
sharesItemType
text: <entity> 24650 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
1087
sharesItemType
text: <entity> 1087 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having f...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
50000
sharesItemType
text: <entity> 50000 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
674
sharesItemType
text: <entity> 674 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having fo...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having four year vesting schedules and 50,000 stock option awards that vested upon issuance....
text
6542
sharesItemType
text: <entity> 6542 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 206,893 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2024, consisting of 131,156 RSU and 24,650 stock option awards having five year vesting schedules, 1,087 RSU having f...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an additional 848 RSU that vest in four approximately equal installments on March 31,...
text
47238
sharesItemType
text: <entity> 47238 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an additional 848 RSU that vest in four approximately equal installments on March 31,...
text
45988
sharesItemType
text: <entity> 45988 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an additional 848 RSU that vest in four approximately equal installments on March 31,...
text
1250
sharesItemType
text: <entity> 1250 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted a...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an additional 848 RSU that vest in four approximately equal installments on March 31,...
text
848
sharesItemType
text: <entity> 848 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted an additional 848 RSU that vest in four approximately equal installments on March 31,...
text
11187
sharesItemType
text: <entity> 11187 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 47,238 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2023, consisting of 45,988 RSU and 1,250 stock option awards having four year vesting schedules. The Company granted ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
405550
sharesItemType
text: <entity> 405550 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stoc...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
164478
sharesItemType
text: <entity> 164478 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stoc...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
113838
sharesItemType
text: <entity> 113838 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stoc...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
127234
sharesItemType
text: <entity> 127234 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stoc...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
1117
sharesItemType
text: <entity> 1117 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock ...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock option awards having two year vesting schedules. The Company granted an additional 1...
text
11418
sharesItemType
text: <entity> 11418 </entity> <entity type> sharesItemType </entity type> <context> The Company granted 405,550 awards to employees under the 2016 Incentive Award Plan during the year ended December 31, 2022, consisting of 164,478 RSU and 113,838 stock option awards having four year vesting schedules and 127,234 stock...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
The Company satisfies stock option exercises and vested stock awards with treasury shares or newly issued shares. Shares available for future stock compensation grants under the 2016 Plan totaled 2.1 million and 2.3 million at December 31, 2024 and 2023, respectively.
text
2.1
sharesItemType
text: <entity> 2.1 </entity> <entity type> sharesItemType </entity type> <context> The Company satisfies stock option exercises and vested stock awards with treasury shares or newly issued shares. Shares available for future stock compensation grants under the 2016 Plan totaled 2.1 million and 2.3 million at December 3...
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
The Company satisfies stock option exercises and vested stock awards with treasury shares or newly issued shares. Shares available for future stock compensation grants under the 2016 Plan totaled 2.1 million and 2.3 million at December 31, 2024 and 2023, respectively.
text
2.3
sharesItemType
text: <entity> 2.3 </entity> <entity type> sharesItemType </entity type> <context> The Company satisfies stock option exercises and vested stock awards with treasury shares or newly issued shares. Shares available for future stock compensation grants under the 2016 Plan totaled 2.1 million and 2.3 million at December 3...
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively.
text
27.8
monetaryItemType
text: <entity> 27.8 </entity> <entity type> monetaryItemType </entity type> <context> The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context>
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively.
text
18.9
monetaryItemType
text: <entity> 18.9 </entity> <entity type> monetaryItemType </entity type> <context> The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context>
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively.
text
23.2
monetaryItemType
text: <entity> 23.2 </entity> <entity type> monetaryItemType </entity type> <context> The actual tax benefits recognized related to stock-based compensation totaled $ 27.8 million, $ 18.9 million and $ 23.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context>
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
The Company provides a 401(k) plan that covers substantially all U.S. employees. Participants can elect to contribute up to 50 % of their eligible earnings on a pre-tax basis, subject to Internal Revenue Service annual limitations.
text
50
percentItemType
text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The Company provides a 401(k) plan that covers substantially all U.S. employees. Participants can elect to contribute up to 50 % of their eligible earnings on a pre-tax basis, subject to Internal Revenue Service annual limitations. </con...
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contribution. Participants fully vest in the employer contributions after three years of ser...
text
8.9
monetaryItemType
text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contrib...
us-gaap:DefinedContributionPlanCostRecognized
The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contribution. Participants fully vest in the employer contributions after three years of ser...
text
7.4
monetaryItemType
text: <entity> 7.4 </entity> <entity type> monetaryItemType </entity type> <context> The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contrib...
us-gaap:DefinedContributionPlanCostRecognized
The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contribution. Participants fully vest in the employer contributions after three years of ser...
text
5.4
monetaryItemType
text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> The U.S.-based plan offers a year-end employer matching contribution, requiring the participant to be an employee at year-end to qualify for the match. Participants with one year or more of service are eligible for the matching contrib...
us-gaap:DefinedContributionPlanCostRecognized
The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred expenses related to these arrangements of $ 4.0 million, $ 3.3 million and $ 2.5 mill...
text
4.0
monetaryItemType
text: <entity> 4.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred ...
us-gaap:DefinedContributionPlanCostRecognized
The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred expenses related to these arrangements of $ 4.0 million, $ 3.3 million and $ 2.5 mill...
text
3.3
monetaryItemType
text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred ...
us-gaap:DefinedContributionPlanCostRecognized
The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred expenses related to these arrangements of $ 4.0 million, $ 3.3 million and $ 2.5 mill...
text
2.5
monetaryItemType
text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company has various defined contribution arrangements for eligible employees of non-U.S. entities. These defined contribution arrangements provide employees with retirement savings and life insurance benefits. The Company incurred ...
us-gaap:DefinedContributionPlanCostRecognized
As of December 31, 2024, the Company’s accounting position is that unremitted foreign earnings are indefinitely reinvested. Therefore, the Company has not recorded deferred foreign withholding taxes on the unremitted foreign earnings and it is not practicable to determine the amount of the additional taxes that would r...
text
73.2
monetaryItemType
text: <entity> 73.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s accounting position is that unremitted foreign earnings are indefinitely reinvested. Therefore, the Company has not recorded deferred foreign withholding taxes on the unremitted foreign earnings ...
us-gaap:UndistributedEarningsOfForeignSubsidiaries
The Company has foreign operating loss carryforwards for which a deferred tax asset of $ 0.1 million has been established as of December 31, 2024. The Company does not have a valuation allowance against this deferred tax asset as of December 31, 2024 based upon its assessment that it is more likely than not that this a...
text
0.1
monetaryItemType
text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company has foreign operating loss carryforwards for which a deferred tax asset of $ 0.1 million has been established as of December 31, 2024. The Company does not have a valuation allowance against this deferred tax asset as of De...
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3 million and $ 16.2 million for uncertain tax positions.
text
6.7
monetaryItemType
text: <entity> 6.7 </entity> <entity type> monetaryItemType </entity type> <context> ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3...
us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3 million and $ 16.2 million for uncertain tax positions.
text
5.2
monetaryItemType
text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3...
us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3 million and $ 16.2 million for uncertain tax positions.
text
20.3
monetaryItemType
text: <entity> 20.3 </entity> <entity type> monetaryItemType </entity type> <context> ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20....
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20.3 million and $ 16.2 million for uncertain tax positions.
text
16.2
monetaryItemType
text: <entity> 16.2 </entity> <entity type> monetaryItemType </entity type> <context> ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, respectively, the Company has a liability for interest and penalties of $ 6.7 million and $ 5.2 million that is associated with related tax liabilities of $ 20....
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
The Company has several minimum purchase commitments for project related supplies totaling $ 15.6 million as of December 31, 2024. In return for the commitment, Medpace receives preferential pricing. The commitments expire at various times through 2029.
text
15.6
monetaryItemType
text: <entity> 15.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company has several minimum purchase commitments for project related supplies totaling $ 15.6 million as of December 31, 2024. In return for the commitment, Medpace receives preferential pricing. The commitments expire at various ...
us-gaap:LongTermPurchaseCommitmentAmount
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
21.7
monetaryItemType
text: <entity> 21.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a c...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
43.7
monetaryItemType
text: <entity> 43.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a c...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
40.5
monetaryItemType
text: <entity> 40.5 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a c...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
9.5
monetaryItemType
text: <entity> 9.5 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a co...
us-gaap:ContractWithCustomerLiabilityCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
7.6
monetaryItemType
text: <entity> 7.6 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a co...
us-gaap:ContractWithCustomerLiabilityCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
2.8
monetaryItemType
text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a co...
us-gaap:ReceivablesNetCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharm...
text
0.5
monetaryItemType
text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers and/or have equity investments in LIB. The Company entered into a MSA dated November 24, 2015 with LIB, a co...
us-gaap:ReceivablesNetCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
28.3
monetaryItemType
text: <entity> 28.3 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into sever...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
15.8
monetaryItemType
text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into sever...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
15.0
monetaryItemType
text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into sever...
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
5.2
monetaryItemType
text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:ContractWithCustomerLiabilityCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
2.5
monetaryItemType
text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:ContractWithCustomerLiabilityCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
1.4
monetaryItemType
text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:ReceivablesNetCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
1.9
monetaryItemType
text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:ReceivablesNetCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
0.1
monetaryItemType
text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:PrepaidExpenseAndOtherAssetsCurrent
Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into several task orders for the Company to perform clinical trial related services. During the ...
text
0.2
monetaryItemType
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> Certain executives and employees of the Company, including the chief executive officer, are members of CinRx’s board of managers and/or have equity investments in CinRx, a biotech company. The Company and CinRx have entered into severa...
us-gaap:PrepaidExpenseAndOtherAssetsCurrent
The Summit Hotel, located on the Medpace campus, is owned by the chief executive officer. Medpace incurs travel lodging and meeting expenses at The Summit. During the years ended December 31, 2024, 2023 and 2022, Medpace incurred expenses of $ 0.3 million, $ 0.4 million and $ 0.3 million at The Summit, respectively.
text
0.3
monetaryItemType
text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The Summit Hotel, located on the Medpace campus, is owned by the chief executive officer. Medpace incurs travel lodging and meeting expenses at The Summit. During the years ended December 31, 2024, 2023 and 2022, Medpace incurred expen...
us-gaap:OperatingCostsAndExpenses
The Summit Hotel, located on the Medpace campus, is owned by the chief executive officer. Medpace incurs travel lodging and meeting expenses at The Summit. During the years ended December 31, 2024, 2023 and 2022, Medpace incurred expenses of $ 0.3 million, $ 0.4 million and $ 0.3 million at The Summit, respectively.
text
0.4
monetaryItemType
text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> The Summit Hotel, located on the Medpace campus, is owned by the chief executive officer. Medpace incurs travel lodging and meeting expenses at The Summit. During the years ended December 31, 2024, 2023 and 2022, Medpace incurred expen...
us-gaap:OperatingCostsAndExpenses
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
2.7
monetaryItemType
text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationsh...
us-gaap:OperatingLeaseCost
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
2.6
monetaryItemType
text: <entity> 2.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationsh...
us-gaap:OperatingLeaseCost
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
2.3
monetaryItemType
text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationsh...
us-gaap:OperatingLeaseCost
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
17.6
monetaryItemType
text: <entity> 17.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relations...
us-gaap:OperatingLeaseRightOfUseAsset
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
19.3
monetaryItemType
text: <entity> 19.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relations...
us-gaap:OperatingLeaseRightOfUseAsset
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
1.6
monetaryItemType
text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationsh...
us-gaap:OperatingLeaseLiabilityCurrent
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
16.5
monetaryItemType
text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relations...
us-gaap:OperatingLeaseLiabilityNoncurrent
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
1.5
monetaryItemType
text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationsh...
us-gaap:OperatingLeaseLiabilityCurrent
The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable inte...
text
18.1
monetaryItemType
text: <entity> 18.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an operating lease for the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relations...
us-gaap:OperatingLeaseLiabilityNoncurrent
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
50.2
monetaryItemType
text: <entity> 50.2 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain member...
us-gaap:OperatingLeaseRightOfUseAsset
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
51.9
monetaryItemType
text: <entity> 51.9 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain member...
us-gaap:OperatingLeaseRightOfUseAsset
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
1.5
monetaryItemType
text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members...
us-gaap:OperatingLeaseLiabilityCurrent
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
62.0
monetaryItemType
text: <entity> 62.0 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain member...
us-gaap:OperatingLeaseLiabilityNoncurrent
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
1.3
monetaryItemType
text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members...
us-gaap:OperatingLeaseLiabilityCurrent
In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. The Company began to occupy the premises in the second quar...
text
63.5
monetaryItemType
text: <entity> 63.5 </entity> <entity type> monetaryItemType </entity type> <context> In 2018, Medpace, Inc. entered into a multi-year lease agreement governing future occupancy of additional office space in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain member...
us-gaap:OperatingLeaseLiabilityNoncurrent
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
6.4
monetaryItemType
text: <entity> 6.4 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseRightOfUseAsset
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
8.5
monetaryItemType
text: <entity> 8.5 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseRightOfUseAsset
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
2.2
monetaryItemType
text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseLiabilityCurrent
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
4.2
monetaryItemType
text: <entity> 4.2 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseLiabilityNoncurrent
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
2.1
monetaryItemType
text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseLiabilityCurrent
10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. The Company has determined th...
text
6.4
monetaryItemType
text: <entity> 6.4 </entity> <entity type> monetaryItemType </entity type> <context> 10 -year option to extend the lease term. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental r...
us-gaap:OperatingLeaseLiabilityNoncurrent
The Company entered into a multi-year lease agreement governing the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the Company's chief executive officer and certain members of his immediate family. The Company assumed occupancy in 2012 and the lease expires in 2027 wi...
text
2.9
monetaryItemType
text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into a multi-year lease agreement governing the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the Company's chief executive officer and certain members of his imm...
us-gaap:OperatingLeaseCost
The Company entered into a multi-year lease agreement governing the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the Company's chief executive officer and certain members of his immediate family. The Company assumed occupancy in 2012 and the lease expires in 2027 wi...
text
1.1
monetaryItemType
text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into a multi-year lease agreement governing the occupancy of office space in a building in Cincinnati, Ohio with an entity that is wholly owned by the Company's chief executive officer and certain members of his imm...
us-gaap:OperatingLeaseCost
respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023 were $ 0.7 million and $ 3.4 million, respectively, in the consolidated balance shee...
text
0.7
monetaryItemType
text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023...
us-gaap:OperatingLeaseRightOfUseAsset
respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023 were $ 0.7 million and $ 3.4 million, respectively, in the consolidated balance shee...
text
3.4
monetaryItemType
text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023...
us-gaap:OperatingLeaseRightOfUseAsset
respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023 were $ 0.7 million and $ 3.4 million, respectively, in the consolidated balance shee...
text
0.9
monetaryItemType
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023...
us-gaap:OperatingLeaseLiabilityCurrent
respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023 were $ 0.7 million and $ 3.4 million, respectively, in the consolidated balance shee...
text
1.5
monetaryItemType
text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023...
us-gaap:OperatingLeaseLiabilityNoncurrent
respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023 were $ 0.7 million and $ 3.4 million, respectively, in the consolidated balance shee...
text
2.5
monetaryItemType
text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> respectively. The operating lease cost was allocated between Total direct costs and Selling, general and administrative in the consolidated statements of operations. The Operating lease right-of-use assets at December 31, 2024 and 2023...
us-gaap:OperatingLeaseLiabilityNoncurrent
The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The Company may contract directly with the private aviation charter for the use of its ai...
text
1.9
monetaryItemType
text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The ...
us-gaap:TravelAndEntertainmentExpense
The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The Company may contract directly with the private aviation charter for the use of its ai...
text
2.0
monetaryItemType
text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The ...
us-gaap:TravelAndEntertainmentExpense
The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The Company may contract directly with the private aviation charter for the use of its ai...
text
2.3
monetaryItemType
text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The ...
us-gaap:TravelAndEntertainmentExpense
The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The Company may contract directly with the private aviation charter for the use of its ai...
text
0.2
monetaryItemType
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The ...
us-gaap:AccountsPayableCurrent
The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The Company may contract directly with the private aviation charter for the use of its ai...
text
0.4
monetaryItemType
text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurs expenses for travel services for company executives provided by private aviation charter companies which is a company controlled by the chief executive officer of the Company (each a “private aviation charter”). The ...
us-gaap:AccountsPayableCurrent
The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in which it held a 99.7 % and 99.6 % common equity interest as of December 31, 2023 and 20...
text
99.7
percentItemType
text: <entity> 99.7 </entity> <entity type> percentItemType </entity type> <context> The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in wh...
us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in which it held a 99.7 % and 99.6 % common equity interest as of December 31, 2023 and 20...
text
99.6
percentItemType
text: <entity> 99.6 </entity> <entity type> percentItemType </entity type> <context> The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in wh...
us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in which it held a 99.7 % and 99.6 % common equity interest as of December 31, 2023 and 20...
text
100
percentItemType
text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company’s assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership (the “Operating Partnership”), of which Agree Realty Corporation is the sole general partner and in whi...
us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest